Investigations are all normal and early treatment can prevent chronicity. A multidisciplinary biopsychosocial approach with the use of antidepressants and cognitive behaviour therapy provides the best chance of pain relief and improved quality of life.
Introduction
There has been considerable controversy about the condition currently called persistent idiopathic facial pain (PIFP) by the International Headache Society Classification ICHD 1 . The term persistent as opposed to chronic is preferred as it implies that relief may be a possible outcome. It is often called atypical facial pain (AFP) 2 . In this text both terminologies PIFP and AFP will be used but it is assumed that these are the same disorders. It may include more than one condition e.g atypical odontalgia, persistent dentoalveolar pain. In the neurosurgical literature it has been termed atypical facial pain and Burchiel emphasized that it excludes disorders for which a cause has been identified and that this is a somatoform disorder diagnosed by psychological testing 3 .
The ICHD Description: is "persistent facial and/or oral pain, with varying presentations but recurring daily for more than 2 hours per day over more than 3 months, in the absence of clinical neurological deficit. See box 1 for criteria .
Box 1: ICHC diagnostic criteria for persistent idiopathic facial pain
Patients are diagnosed into this category frequently as an exclusion diagnosis however with improved appreciation of the need to take careful history patients who were previously put in this category may in fact have other identifiable causes of pain such as neuropathic pain and myofascial pain and so do not belong here 4, 5 et al.
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The cause remains unknown but it has been suggested that it could be a consequence of deafferentation and central sensitization but is still is not clear if peripheral or central mechanisms are involved 4, 6 . Not surprisingly psychological factors are identified but these could also be as a consequence of having a chronic pain, lack of diagnosis and attitude of health care professionals. Gustin et al have shown that psychological and psychosocial factors are universal to chronic pain and are no different between orofacial pain patients relative to diagnosis 7 .
Epidemiology
A study in primary care in the Netherlands found an incidence rate of 4.4 [95% CI: 3.2-5.9] for atypical facial pain with a predominance in females 75% and mean age of 45.5 (SD 19.6) 8 . A review of 97 patients with facial pain attending a neurological tertiary centre in Austria classified 21% as having PIFP 9 . In a UK community based study chronic orofacial pain was identified in 7% of the population and these patients often have other unexplained symptoms such as chronic widespread pain, irritable bowel syndrome and chronic fatigue and show high levels of health anxiety, reassurance seeking behaviour and recent adverse events 10 .
Risk factors:
 psychological distress  maladaptive response to illness  female  retrospective perception of unhappiness in childhood 11 , 12 .
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On the other hand in the large Finish birth cohort study, 5,696, a question on facial pain was added and a correlation was found with optimism which was important factor in reducing facial pain 13 .
Using the Chronic Graded Pain Scale Chung et al 14 showed in a population study of elderly Koreans that disability was high in nearly 50% of patients with chronic facial pain but lower than for other forms of facial pain such as burning mouth and joint pain.
Major predictors of outcome:
 patients' illness beliefs such as serious consequences of continued pain  low personal control 15  optimism 13
Clinical features
If there is a history of trauma, extensive dental work prior to the pain e.g 6 months, then the pain may be neuropathic and so should not be classified under this category. Trained staff may be able to establish a more accurate diagnosis which avoids the label of PIFP 16 . Taking a careful history which includes family history, social history and performing psychological testing is imperative as comorbidity is very common 17 , 18 . 20 have both used the ICHD criteria to determine if the criteria are correct and both suggested alterations. Zebenholzer 20 6 put forward very simple criteria for PIFP under which most chronic orofacial pains could be classified .
Investigations
Many of these patients will have had numerous investigations including MRIs and yet is it questionable whether they should have MRI scans as these are normal.
Lange 21 showed that patients with PIFP do not have neurovascular compression of their trigeminal nerve at the route entry zone. However PIFP patients have brain morphology changes consistent with those who have chronic pain 22 but studies suggest that somatosensory processing is not used to maintain the pain 23 .
Conditions such as temporal arteries may need to be excluded in patients over 50 years by appropriate investigations. 27 . These tests often show high levels of disability. A study of German University centres managing chronic facial pain showed that only 32% ( 6/19) did psychological testing 9 .
Overall management 7
Often by the time these patients present in a specialist clinic they have been to numerous dentists and medical practitioners, attended at several secondary care centers , had a significant number of investigations and some treatments that may have included irreversible dental treatments 19 . Studies in a German secondary care sectors have shown inadequate management 9 and similar findings have been reported in the UK 28 . A qualitative study of doctors' dentists and patients in the UK showed that current management of PIFP was ineffective and unsatisfactory from everybody's perspective 29 . They identified especially relationships between clinician and patient and lack of psychological support. 
Pharmacologic Treatment Options
There are no high quality evidence based treatments. When List did a systematic review of pharmacological treatments for facial pain they found very few studies and many of them were mixed including both temporomandibular disorders and atypical facial pain 30 . Probably the first trial was by Lascelles in 1966 who used monoamine oxidase inhibitors in a cross over trial of 40 patients with PIFP and depression with some success 31 .
Treatment is often specialty biased 32 . A survey among UK medical and dental practitioners showed that the most common drugs used were antidepressants 2 .
Some selective serotonin reuptake inhibitors (SSRIs) or selective noradrenalin and serotonin inhibitors (SNRIs) are used 33 . Anticonvulsants drugs have not been shown to be effective.
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Patients with significant psychiatric co-morbidity will benefit from an assessment with a liaison psychiatrist prior to being referred to a cognitive behavior program.
Those studies that have been the subject of RCT are shown in table 2.
Table 2 lists drug therapies that have been used in RCTs Nonpharmacologic Treatment Options
A systematic review of psychological therapies identified 17 trials in orofacial pain but there was a high risk of bias so only weak evidence was found to support their use 34 . A controlled patient blinded study in 41 PIFP compared active hypnosis for 5 one hour individual sessions with relaxation and showed that significant pain relief was obtained in susceptible adults but there was a need for further psychological support to help with coping strategies and other psychological issues 35 .
It is crucial to stress that a cause cannot be found in all cases and this does not mean that the pain is not real. Patients need to move away from looking for a cause and develop coping strategies, pacing and targeting goals which would reduce interference with quality of life 36 and these sessions may be short 37 .
Reassurance with an explanation is required rather than just a statement that "things will get better". Written patient information is helpful and these can be found on the other chronic pain as cognitive behavior therapy has been shown to be effective in chronic pain. 38 , 39 
Combination Therapies
Harrison 40 showed that the best outcome were obtained with a combination of an antidepressant with cognitive behavior therapy see table 2 .
Surgical Treatment Options
In their series of 256 patients treated with Gamma Knife surgery Balamucki 41 included 20 with PIFP and in this group 60% had pain relief with 15% coming off all medication and up to 42% indicated that their quality of life had improved. However there was a recurrence rate of 33%. Radiofrequency thermocoagulation nor microvascular decompression gave satisfactory long term pain relief in 16 patients 42 .
Evaluation of Outcome and Long-Term Recommendations
There is little data on prognosis. Feinmann 43 followed up patients who had undertaken a trial of dothiepin and at 4 years showed that improvement had been maintained albeit with continuation of dothiepin, withdrawal at 6 months had resulted in return of pain. Long term antidepressants may be needed as well as psychological support to reduce further health utilization.
Summary/Discussion
There remains little high quality evidence on PIFP. Potentially this diagnosis is being used less often as more detailed history and examinations are done which enable more accurate diagnosis e.g neuropathic pain, burning mouth syndrome, temporomandibular disorders. These patients have increased vulnerability to chronic pain and will present with many other medically unexplained symptoms and personality disorders. Their health utilization is high as they seek to obtain a diagnosis, exclude a serious cause for their disease and then get treatment. They feel abandoned as once clinicians have excluded a serious or treatable cause they are reassured and discharged from clinics. Reassurance on its own is insufficient and it must be associated with written information and coping strategies. There is a paucity of high quality trials confounded by the wide range of diagnostic criteria used. Some trials will include a variety of chronic orofacial pain conditions and do not report on them separately. A systematic review showed weak evidence for psychological therapy on its own but one RCT showed that when combined with antidepressants improved outcomes are possible. PIFP is a long term condition especially if not managed early and patients need to be positively reassured that they are believed and that they have a real pain but its cause currently remains unknown. 
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